{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:15:06Z","timestamp":1787314506204,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omton.2025.201034","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:49:21Z","timestamp":1755154161000},"page":"201034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Lina","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanina","family":"Mutisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Robatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wartenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"B\u00e4riswyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Z\u2019graggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1637-0730","authenticated-orcid":false,"given":"Mirjam","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201034_bib1","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201034_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib3","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2025.201034_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.33594\/000000326","article-title":"Targeting pancreatic ductal adenocarcinoma (PDAC)","volume":"55","author":"Parrasia","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omton.2025.201034_bib5","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic Adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201034_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1055-9965.EPI-08-0880","article-title":"Alcohol Intake and Pancreatic Cancer Risk: A Pooled Analysis of Fourteen Cohort Studies","volume":"18","author":"Genkinger","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.omton.2025.201034_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.21147\/j.issn.1000-9604.2020.06.04","article-title":"Current epidemiology of pancreatic cancer: Challenges and opportunities","volume":"32","author":"Luo","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.omton.2025.201034_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10689-008-9214-8","article-title":"Family history is a significant risk factor for pancreatic cancer: Results from a systematic review and meta-analysis","volume":"8","author":"Permuth-Wey","year":"2009","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.omton.2025.201034_bib11","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2019.04.04","article-title":"Adjuvant treatment for pancreatic cancer","volume":"4","author":"Klaiber","year":"2019","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omton.2025.201034_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: Current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omton.2025.201034_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.omton.2025.201034_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030278","article-title":"Clinical outcomes of conversion surgery after neoadjuvant chemotherapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer: A single-center, retrospective analysis","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.201034_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00245","article-title":"Neoadjuvant treatment in pancreatic cancer","volume":"10","author":"Oba","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ags3.12176","article-title":"Immunotherapy for pancreatic cancer: Barriers and breakthroughs","volume":"2","author":"Torphy","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.omton.2025.201034_bib17","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: A changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.omton.2025.201034_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00535-009-0013-2","article-title":"Signal transduction in pancreatic stellate cells","volume":"44","author":"Masamune","year":"2009","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.omton.2025.201034_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1535-7163.MCT-06-0686","article-title":"Tumor-stroma interactions in pancreatic ductal adenocarcinoma","volume":"6","author":"Mahadevan","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2025.201034_bib20","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201034_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ags3.12225","article-title":"Role of the tumor microenvironment in pancreatic cancer","volume":"3","author":"Murakami","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.omton.2025.201034_bib22","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201034_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add9990","article-title":"TREM1 activation of myeloid cells promotes antitumor immunity","volume":"15","author":"Juric","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2025.201034_bib24","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting Edge: Inflammatory Responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib25","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","article-title":"A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response","volume":"170","author":"Bleharski","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2007.04.011","article-title":"Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin","volume":"111","author":"El Mezayen","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.omton.2025.201034_bib27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4049\/jimmunol.1402303","article-title":"Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1","volume":"194","author":"Read","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23808-2","article-title":"Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses","volume":"8","author":"Alflen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201034_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.174.1.517","article-title":"Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine","volume":"174","author":"Schenk","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.02.043","article-title":"TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives","volume":"177","author":"Tammaro","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omton.2025.201034_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2007.11.021","article-title":"The TREM-1\/DAP12 pathway","volume":"116","author":"Tessarz","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.omton.2025.201034_bib32","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1172\/JCI30602","article-title":"TREM-1 - Expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases","volume":"117","author":"Schenk","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201034_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.omton.2025.201034_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep13351","article-title":"Integrated transcriptomics establish macrophage polarization signatures and have potential applications for clinical health and disease","volume":"5","author":"Becker","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201034_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201034_bib36","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201034_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1547466","article-title":"The role of type I interferon signaling in myeloid anti-tumor immunity","volume":"16","author":"Meyer","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107212","article-title":"TREM1: Activation, signaling, cancer and therapy","volume":"204","author":"Li","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omton.2025.201034_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201034_bib40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.gendis.2022.10.019","article-title":"The role of TGF-\u03b2 in the tumor microenvironment of pancreatic cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.omton.2025.201034_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193068","article-title":"Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers","volume":"11","author":"Taherian","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omton.2025.201034_bib42","article-title":"Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2025.201034_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib44","doi-asserted-by":"crossref","first-page":"50735","DOI":"10.18632\/oncotarget.9383","article-title":"Targeting tumor-associated macrophages to combat pancreatic cancer","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201034_bib45","first-page":"1461","article-title":"Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models","volume":"9","author":"C\u00e9spedes","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omton.2025.201034_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.927440","article-title":"Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology?","volume":"12","author":"Muller","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/ERC-21-0297","article-title":"TREM1 fosters an immunosuppressive tumor microenvironment in papillary thyroid cancer","volume":"29","author":"Zhao","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.200704-641OC","article-title":"TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer","volume":"177","author":"Ho","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omton.2025.201034_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734959","article-title":"Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes","volume":"11","author":"Pullikuth","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib50","article-title":"Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma","volume":"11","author":"Ford","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2014.05.001","article-title":"A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock","volume":"21","author":"Sigalov","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.omton.2025.201034_bib52","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.molpharmaceut.7b00711","article-title":"Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer","volume":"14","author":"Shen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omton.2025.201034_bib53","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.2174\/1381612822666160826110539","article-title":"Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer","volume":"22","author":"Bosco","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omton.2025.201034_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07697-1","article-title":"Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-\u03b1 secretion","volume":"20","author":"Tekin","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/15384047.2017.1416932","article-title":"The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC)","volume":"19","author":"Lianyuan","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omton.2025.201034_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113767","article-title":"Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLC","volume":"43","author":"Lin","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201034_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000308","article-title":"Interferon gamma Inhibits CXCL8\u2013CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6145-8","article-title":"IFN-\u03b3down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib59","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","article-title":"T cells in pancreatic cancer stroma","volume":"27","author":"Goulart","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omton.2025.201034_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201034_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-15-1032","article-title":"IFN\u03b3 and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma","volume":"6","author":"Long","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201034_bib62","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.201034_bib63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2025.201034_bib64","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.omton.2025.201034_bib65","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.201034_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.omton.2025.201034_bib67","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omton.2025.201034_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.201034_bib69","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2025.201034_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omton.2025.201034_bib71","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/bioinformatics\/bty124","article-title":"GDCRNATools: an R\/Bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omton.2025.201034_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omton.2025.201034_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2435-4","article-title":"Single sample scoring of molecular phenotypes","volume":"19","author":"Foroutan","year":"2018","journal-title":"BMC Bioinf."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:59:49Z","timestamp":1760147989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2950329925001031"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201034","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201034"}}